Loading organizations...
§ Private Profile · Berlin, Berlin, Germany
her1 is a company.
her1 has raised $6.5M across 1 funding round.
Key people at her1.
her1 has raised $6.5M in total across 1 funding round.
her1 develops high-quality nutritional supplements and wellness products tailored for women, primarily supporting gut health and overall well-being. The company crafts natural, plant-based, gluten-free, and sugar-free formulations from locally sourced whole foods. Their product line addresses female health, promoting beauty and vitality through a holistic internal approach.
Chanyu Xu, a serial FoodTech entrepreneur, founded her1 in 2017. Her insight recognized genuine health and beauty originate internally, stemming from the deep connection between gut health and broader physiological functions. This understanding drove her to establish a brand empowering women with natural wellness solutions.
her1 serves women seeking natural methods to enhance their gut health, holistic well-being, and inner beauty. The company's vision is to become the leading digital health impact organization in the female health and wellness sector. It innovates, providing accessible and effective solutions supporting women throughout their personal health journeys.
her1 is a Berlin-based direct-to-consumer wellness company founded in 2017 that develops natural, plant-based ingestible products to support women's health by targeting gut health, microbiome balance, and related issues like skin, hormones, mood, sleep, and holistic wellbeing.[1][2][3] Its flagship product, Inner Beauty—a "pink drink" with over 25 billion active microorganisms per serving—launched in 2019, followed by Gut One, a probiotic and B-vitamin supplement for gut-brain axis support, both available via subscription.[1][2][3] her1 serves women across Europe, solving taboos around digestive and female-specific health through science-backed, EU organic-certified (DE-ÖKO-070), gluten- and sugar-free blends from locally sourced whole foods, with strong growth including 815% YoY in the year prior to 2021 and 55% quarterly increases, backed by €9M total funding including a €5.5M Series A in 2021 led by Five Seasons Ventures.[1][2][3][4]
The company employs a 35-person team focused on product innovation, European expansion (starting from German-speaking markets), and multilingual accessibility, aiming to become the leading digital health impact brand for female wellbeing across life stages like pregnancy and menopause.[1][2][4]
her1 was founded in 2017 by serial FoodTech entrepreneur Chanyu Xu, who drew from her expertise to address gut health as the foundation of overall wellbeing, encapsulated in her mantra: "you are what you eat and everything starts from within."[1][2] After over a year of research and development, the company launched its debut product, Inner Beauty, in 2019, marking early traction in German-speaking countries with natural probiotics and prebiotics.[1][3]
Pivotal moments include rapid scaling—achieving over 54k loyal recurring customers, 25k+ Instagram followers, and double-digit month-over-month growth by 2021—culminating in the €5.5M Series A round in June/July 2021, led by Five Seasons Ventures with participation from Rheingau Founders and IBB Ventures, bringing total funding to €9M.[1][2][3][4] This funding fueled team expansion in finance, marketing, and product roles, plus new launches like Gut One.[1][2]
her1 rides the exploding gut health and women's wellness trends, tapping into rising microbiome awareness amid a $300B global supplements market and $60B probiotics segment, where 62% of people face yearly digestive issues often shrouded in taboo.[4] Timing aligns with post-2020 health consciousness surges, European DTC e-commerce growth, and demand for "inside-out" beauty/health solutions over topical fixes, amplified by research linking gut to mental, immune, and skin health.[2][3][4]
Market forces like sustainable, organic consumer preferences and life-stage personalization (e.g., pregnancy vitamins, menopause support) favor her1's Europe-focused expansion from a Berlin base.[1][4] It influences the ecosystem by pioneering female-led FoodTech in ingestibles, inspiring "for women, by women" brands, and validating DTC models in wellness tech with data-driven scaling.[4]
her1 is poised to dominate European women's gut-centric wellness with its science pipeline, subscription retention, and funding momentum, potentially launching products for hormone, sleep, and mood needs while scaling multilingual DTC.[1][2][4] Trends like AI-personalized nutrition, deeper microbiome science, and sustainability mandates will shape its path, possibly fueling Series B for UK/France penetration or US entry amid $60B+ probiotics growth.[4]
As a 2017-founded trailblazer with 815% early surges, her1 exemplifies how gut health innovation unlocks female wellbeing at scale—watch for it to redefine DTC ingestibles across life stages.[2][4]
her1 has raised $6.5M across 1 funding round. Most recently, it raised $6.5M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 21, 2021 | $6.5M Series A | Five Seasons Ventures | IBB Ventures, Rheingau Founders | Announced |
her1 has raised $6.5M in total across 1 funding round.
her1's investors include Five Seasons Ventures, IBB Ventures, Rheingau Founders.
Key people at her1.
